Hermoso, Cristine .

HRN: 22-43-69  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2023
CEFUROXIME 1.5GM (VIAL)
02/23/2023
02/24/2023
IV
1.5
Q8
Uti
02/28/2023
CEFUROXIME 500MG (TAB)
02/28/2023
03/07/2023
PO
500
Bid
Sp 1' CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: